Merus to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:17 am UTC| Business
UTRECHT, The Netherlands, June 01, 2017 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, Ph.D., Chief...
Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients
Jun 01, 2017 11:15 am UTC| Business
CANTON, Mass., June 01, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that one of the largest managed care organizations with approximately 8 million Medicare Part D lives has added Xtampza® ER to...
Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients
Jun 01, 2017 11:15 am UTC| Business
CANTON, Mass., June 01, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that one of the largest managed care organizations with approximately 8 million Medicare Part D lives has added Xtampza® ER to...
Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients
Jun 01, 2017 11:15 am UTC| Business
CANTON, Mass., June 01, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that one of the largest managed care organizations with approximately 8 million Medicare Part D lives has added Xtampza® ER to...
Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients
Jun 01, 2017 11:15 am UTC| Business
CANTON, Mass., June 01, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that one of the largest managed care organizations with approximately 8 million Medicare Part D lives has added Xtampza® ER to...
Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients
Jun 01, 2017 11:15 am UTC| Business
CANTON, Mass., June 01, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that one of the largest managed care organizations with approximately 8 million Medicare Part D lives has added Xtampza® ER to...
Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients
Jun 01, 2017 11:15 am UTC| Business
CANTON, Mass., June 01, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that one of the largest managed care organizations with approximately 8 million Medicare Part D lives has added Xtampza® ER to...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows